The growing problem of pediatric allergy prevalence prevention
Download
1 / 57

The Growing Problem of Pediatric Allergy: - PowerPoint PPT Presentation


  • 400 Views
  • Updated On :

The Growing Problem of Pediatric Allergy: Prevalence & Prevention. William J. Cochran, MD, FAAP Department of Pediatric GI & Nutrition Geisinger Clinic. Allergy Prevalence. Affects as many as 50 million Americans Up to 30% in some populations, particularly developed countries

Related searches for The Growing Problem of Pediatric Allergy:

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'The Growing Problem of Pediatric Allergy:' - Patman


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
The growing problem of pediatric allergy prevalence prevention l.jpg

The Growing Problem of Pediatric Allergy:Prevalence & Prevention

William J. Cochran, MD, FAAP

Department of Pediatric GI & Nutrition

Geisinger Clinic


Allergy prevalence l.jpg
Allergy Prevalence

  • Affects as many as 50 million Americans

  • Up to 30% in some populations, particularly developed countries

  • In the U.S. allergies are a leading cause of chronic disease

  • Overall the incidence of allergies are on the rise

  • Food allergies are most common in infants and children

American Academy of Allergy, Asthma and Immunology (AAAAI). The Allergy Report: Science Based Findings on the Diagnosis & Treatment of Allergic Disorders, 1996- 2001


Slide3 l.jpg

Adverse Reactionsto Food

Pharmacological

(Toxic)

Non

Pharmacological

  • Bacterial food poisoning

  • Scromboid fish poisoning

  • Caffeine

  • Tyramine

  • Histamine

Non Immune

Mediated

Immune

Mediated

  • Lactase deficiency

  • Galactosemia

  • Pancreatic insufficiency

  • Allergies:

  • Dermatologic

  • GI

  • Respiratory

  • Anaphylaxis


Food allergies l.jpg
Food Allergies

  • In the U.S., 7 million affected by food allergies

  • Infants and children particularly prone to allergy

  • Occur in 8 percent of children less than 6 years of age

  • Food allergies are the leading cause of anaphylactic reactions treated in the ER in US

  • Approximately 100 Americans, mostly children, die annually from food-induced anaphylaxis

    • Peanut allergy is the most common

Allergy, Principles and Practice, 5th Ed., E. Middleton et al, ed. Mosby, St. Louis, 1998.

AAAAI Board of Directors. Journal of Allergy and Clinical Immunology 102 (2):173-6. 1998.


Most common food allergy manifestations l.jpg
Most Common Food Allergy Manifestations

  • Gastrointestinal

    • Oral allergy syndrome

    • Immediate GI hypersensitivity

    • Food allergy induced enterocolitis / enteropathy

    • Eosinophilic gastroenteritis

  • Respiratory

    • Allergic rhinitis

    • Asthma

  • Skin

    • Atopic dermatitis or eczema

    • Urticaria (hives)


Spectrum of allergy manifestations l.jpg
Spectrum of Allergy Manifestations

IgE Mediated

MixedMechanism

Non-IgEMediated

Skin

Acute urticariaAngioedema

Atopicdermatitis

Dermatitisherpetiformes

GI

Immediate GIhypersensitivity

Oral allergysyndrome

Eosinophilicgastroentero-colitis

Protein inducedenterocolitis

Respiratory

Acute RAD

(High riskanaphylaxis)

Asthma

(Risk ofanaphylaxis)

Food inducedhemosiderosis

Heiner syndrome

Common

Uncommon

Adopted from HA Sampson, 2000


Atopic dermatitis l.jpg
Atopic Dermatitis

  • The most common chronic skin disease in children.

  • In 80% to 90% of the cases, onset of the disease occurs before 5 to 7 years of age

  • Signs and symptoms

    • Rash: Erythematous patches with papules on the face, neck and extensor surfaces. Flexural lesions later.

    • Pruritis

    • Skin dryness, excoriations, erosions

    • Distress, irritability.

Drake et al. J Am Acad Dermatol 1992;26:485-8.


Trends in prevalence of atopic dermatitis l.jpg
Trends in Prevalence of Atopic Dermatitis

*Secular trends in the UK

Eichenfield et al , 2003 Pediatrics 111: 608-16


Atopic dermatitis significance l.jpg
Atopic Dermatitis: Significance

  • Atopic dermatitis in the U.S.

    • Prevalence 10-20% overall†

    • Affects 15 million Americans‡

    • 17% prevalence by 6 months of age*

    • 7 million visits per year ‡

  • Up to 60% of children with severe atopic dermatitis have food hypersensitivity**

† NIH- HHS Publication No. 03-4272, Rev April 2003

‡ CDC Nat Ctr for Health Statistics Vital and Health Statistics Series, 1996, 13:134

* Moore MM - Pediatrics - 01-MAR-2004; 113(3 Pt 1): 468-74

** Burkes et al. J Pediatr 1998, 132(1):132-610


Atopic dermatitis and quality of life l.jpg
Atopic Dermatitis and Quality of Life

  • In infants

    • Itchiness & Irritability & Altered Sleep

    • Pain / Colic when associated to GI allergy

    • Disruption of family- child interactions

  • In children

    • Disruption of daily routine

    • Sleep deprivation, nighttime scratching during all stages of sleep

    • Affects school, social interactions, personal relationships, and self-consciousness

Howlett et al. Br J Dermatol 1999;140:381-4.

Reuveni et al. Arch Pediatr Adoles Med 1999;153:249-53  

Chamlin et al. Pediatrics 2004; 114(3); 607-11  


Atopic dermatitis significance13 l.jpg
Atopic Dermatitis: Significance

  • Healthcare Costs in the U.S.

    • 1.6 billion (conservative)

    • 3.8 billion (all inclusive)

Ellis CN, Drake et al. J Am Acad Derm 2002, 46: 361-70


Atopic dermatitis significance14 l.jpg
Atopic Dermatitis: Significance

  • May be the first step in the Allergy March: the relationship between allergic manifestations throughout life

    • Approximately 75- 80% of atopic dermatitis patients develop allergic rhinitis

    • More than 50% of atopic dermatitis patients develop asthma

Leung DY - J Allergy Clin Immunol - 01-DEC-2003; 112(6 Suppl): S117Spergel J Allergy Clin Immunology 2003; 112 (6 Suppl): S 118-27


The allergic march l.jpg
The Allergic March

Atopic GI and dermal allergy

Upper respiratory tract (rhinitis, rhino-conjunctivitis, allergic otitis media)

Lower respiratory tract (wheezing)

Allergic asthma

Cantani, 1999 Invest Allergol Clin Immunol 9(5)- 314-20


Increasing prevalence of asthma atopy l.jpg
Increasing Prevalence of Asthma & Atopy

Ninan et al., 1992; BMJ 304: 873-75


Diagnosis of food allergy l.jpg
Diagnosis Of Food Allergy

  • History

    • Food(s) / Quantity / Timing / Reproducibility

    • Validated by challenge in 30-40% of cases

  • Skin tests

    • False positive results are common

    • Best use is as a negative predictor

  • RAST

    • Consider for those with cutaneous involvement

  • CAP-FEIA (Fluorescein Enzyme Immunoassay)

    • Food >95% PPV

      • Egg 7kUa/L

      • Milk 15 kUa/L

      • Peanut 14 kUa/L

      • Fish 20kUa/L


Diagnosis of food allergy18 l.jpg
DIAGNOSIS OF FOOD ALLERGY

  • Endoscopy and biopsy

  • Double-blind placebo-controlled food challenges: "gold standard"


Food allergy treatment l.jpg
Food Allergy — Treatment

  • Avoidance

    • Meticulous attention to labels

    • Education on sources of “hidden foods”

  • Extensive hydrolysate (hypoallergenic) formulas

    • 95% <1,500 Daltons

  • Amino acid formulas

  • Partially hydrolyzed formulas are not hypoallergenic

  • Those with severe allergy should have EpiPen


Food allergy prevention l.jpg
Food Allergy — Prevention

  • Tertiary prevention

    • Treatment to avoid recurrence of symptoms

  • Secondary prevention

    • Suppress disease expression after sensitization

  • Primary prevention

    • Prevention of sensitization

Zeiger, Pediatrics, 2003; 111:1662-1671


Preventing pediatric allergy l.jpg
Preventing Pediatric Allergy

  • Allergy, particularly atopic dermatitis, is a significant health issue

    • High incidence in developed countries

    • Increasing incidence and prevalence

    • High costs

    • Impact on quality of life

    • Allergy March may greatly magnify the problem

Primary Prevention is a Priority


Traditional prevention strategies l.jpg
Traditional Prevention Strategies

  • Nutritional strategies recommended for decreasing risk in the general pediatric population

    • Breast feeding

    • Delayed introduction of solid foods

AAP, Pediatric Nutrition Handbook, 2003


Traditional prevention strategies25 l.jpg
Traditional Prevention Strategies

  • Nutritional strategies recommended for decreasing risk in high risk infants

    • Maternal allergen avoidance during breast feeding

      • Nuts, eggs, cow’s milk, fish

    • Dietary avoidance / exclusion of allergens during and after weaning

      • Cow’s milk >1 year of age

      • Egg >2 years of age

      • Nuts and fish >3 years of age

    • Use of extensively hydrolyzed (hypoallergenic) formulas

    • Soy formula is of no benefit

AAP, Pediatric Nutrition Handbook, 2003


Identifying at risk infants l.jpg
Identifying “At Risk” Infants

One parent or sibling with history of AD, urticaria, allergic rhinitis(hay fever) or asthma = “At Risk” by Family History

Risk by Parental Hx.*

Medium

Low

High

Percentage of newborns

Likelihood of developing allergy Sx

*Approximate numbers in developed countries. Adapted from1. Bousquet J. et al. J Allergy Clin Immunol 1986;78: 1019-10222. Halken S et al. Allergy 2000;55: 793-8023. Kjellman N. et al. Acta Paediatr Scan 1977;66: 565-714. Exl BM, Nutr Res 2001;21: 355-79


Predicting pediatric allergy l.jpg
Predicting Pediatric Allergy

Medium

Risk by Parental Hx.*

Low

High

Percentage of newborns

Likelihood of developingallergy Sx

Actual # of children/100

who will develop allergies

*Approximate numbers in developed countries


Predicting pediatric allergy28 l.jpg
Predicting Pediatric Allergy

Medium

Risk by Parental Hx.

Low

High

Percentage of newborns

Likelihood of developing allergy Sx

Actual # of children/100

who will develop allergies

There is no good public health mechanism to predict all children who will develop allergy. At least half of infants who go on to develop allergy could not have been predicted


Food allergies 90 accounted for by 5 foods l.jpg
Food Allergies: 90% accounted for by 5 foods

5 Most Common Allergens

  • Cow Milk

  • Soy

  • Wheat

  • Peanuts/Tree nuts

  • Egg

Other

  • Cow’s milk: the most common antigen infants are exposed to

  • All routine infant formulas are made with cow’s milk protein


Protein size and allergenicity l.jpg
Protein size and Allergenicity

Low Molecular Weight

High Molecular Weight

Immune System

Potential for Hypersensitivity (Allergic Reaction)


Hydrolyzed protein l.jpg
Hydrolyzed Protein

Hydrolysis

Intact

Protein

Hydrolyzed

Protein

Hydrolyzed proteins have a lower chance of inducing sensitization


Hydrolysis can reduce allergenicity of cow milk proteins l.jpg
Hydrolysis Can Reduce Allergenicity of Cow Milk Proteins

Median Molecular Weight of Infant Formulas


Distribution of peptide molecular weight l.jpg
Distribution of Peptide Molecular Weight (%)


Hydrolysate formulas in allergy risk reduction l.jpg
Hydrolysate Formulas in Allergy Risk Reduction

 Over the last decade, a growing body of evidence suggests that exclusive feeding with an extensive or a partial hydrolysate may reduce the incidence of allergy compared to intact cows milk protein in non-breast fed infants.


Slide35 l.jpg
Cumulative Incidence of Atopic ManifestationsExtensively Hydrolyzed Casein Formula vs Cow Milk Formula in Prevention Studies

p<0.02

p=0.032

p=0.025

p=NS

* Graph depicts only published, peer-reviewed, prospective trials. Studies up to 12 mo of Age

** For all extensively hydrolyzed casein formula studies, AM includes AD as one of the allergic outcomes assessed.

*** 9 months: Oldaeus 1997; 12 months: Von Berg 2003, Zeiger 1995, Mallet 1992


Slide36 l.jpg
Cumulative Incidence of Atopic DermatitisExtensively Hydrolyzed Casein Formula vs Cow Milk Formula in Prevention Studies

p<0.005

p=0.006

p=0.059

p=0.007

p=NS

* Graph depicts only published, peer-reviewed, prospective trials.

** 9 months: Oldaeus 1997; 12 months: Von Berg 2003, Zeiger 1995, Mallet 1992; 18 months: Chandra 1989


Slide37 l.jpg
Cumulative Incidence of Atopic ManifestationsPartially Hydrolyzed Whey Formula vs Cow Milk Formula in Prevention Studies

p<0.05

p<0.05

p=0.021

p<0.05

p<0.001

p=NS

p=0.063

p<0.05

p=0.109

* Graph depicts only published, peer-reviewed, prospective trials with data collection at time points ≤12 months.

** For all studies except Becker 2004, AM includes AD as one of the allergic outcomes assessed; for Becker 2004, AM refers to asthma alone.

*** 4 months: Vandenplas 1988; 6 months: Exl 2000, De Seta 1994; 12 months: Becker 2004, Von Berg 2003, Chandra 1997, Marini 1996,

Vandenplas 1995, Willems 1993

**** p-values in italics indicate that no p-value is reported in publication; p-value is based on calculated OR and CI


Slide38 l.jpg
Cumulative Incidence of Atopic DermatitisPartially Hydrolyzed Whey Formula vs Cow Milk Formula in Prevention Studies

p<0.05

p=NS

p=0.004

p<0.02

p<0.05

p>0.05

p=0.048

p>0.05

* Graph depicts only published, peer-reviewed, prospective trials with data collection at timepoints ≤12 months.

** 4 months: Vandenplas 1988; 6 months: Exl 2000; 12 months: Von Berg 2003, Chandra 1997, Marini 1996, Vandenplas 1995, Tsai 1991

**** p-values in italics indicate that no p-value is reported in publication; p-value is based on calculated OR and CI


Slide39 l.jpg
Effect of Hydrolyzed Cow Milk Formulafor Allergy Prevention the First Year of LifeThe German Infant Nutritional Intervention (GINI) Study

  • Independent, government-sponsored study

  • Double blind randomized study

  • 2,252 high-risk infants randomized at birth to:

    • Intact cow milk formula

    • Partially hydrolyzed whey formula

    • Extensively hydrolyzed casein formula

    • Extensively hydrolyzed whey formula

  • As needed, randomized formula was given to 6 months of age (no other foods besides breast milk)

  • Allergic manifestations assessed at 1, 4, 8,12 mo

    • Atopic dermatitis

    • Allergic urticaria

    • Food allergy with manifestation in the GI tract

Von Berg et al., 2003J Allergy Clin Immunol 111(3): 533-40


Slide40 l.jpg
Effect of Hydrolyzed Cow Milk Formulafor Allergy Prevention the First Year of LifeThe German Infant Nutritional Intervention (GINI) Study

  • 2,252 infants enrolled in the study:

    • 889 exclusively breastfed to 4 mo

    • 945 infants included in per protocol

    • 418 infants either non-compliant or drop-outs

      • Extensively hydrolyzed casein had significantly higher number of non-compliant subjects than other formula groups (p=0.02)

  • Incidence of allergic manifestation at 12 months was 13%

    • 89% of all allergic manifestation was atopic dermatitis

  • 12 month results published, 3-year publication pending, 6-year follow-up planned

Von Berg et al., 2003J Allergy Clin Immunol 111(3): 533-40


Risk of ad at 12 months adjusted odds ratio l.jpg
Risk of AD at 12 months: Adjusted Odds Ratio

1.0

0.81

19% risk reduction vs CMF

P - NS vs CMF

0.56

44% risk reduction vs CMF

P< 0.048 vs CMF

0.42

58% risk reduction vs CMF

P< 0.007 vs CMF

Von Berg et al., 2003J Allergy Clin Immunol 111(3): 533-40


Cumulative incidence of atopic dermatitis l.jpg
Cumulative Incidence of Atopic Dermatitis

3 Yr. GINI study : Findings not published. Results presented at ESPACI Meeting, 2003


Gini study considerations l.jpg
GINI Study Considerations

  • Lack of efficacy of extensively hydrolyzed whey formula

    • Method of hydrolysis is as important as degree of hydrolysis

  • Drop-out rate highest with extensively hydrolyzed casein

  • Blinding difficult with extensive hydrolysates

  • Statistical Analysis

    • Statistically significant for both extensively hydrolyzed casein formulaand partially hydrolyzed whey formula for atopic dermatitis

    • Statistically significant for extensively hydrolyzed casein formula but not partially hydrolyzed whey formula for all atopic manifestations

Von Berg et al., 2003J Allergy Clin Immunol 111(3): 533-40


Slide44 l.jpg
Meta-Analysis: Formulas containingHydrolysed Protein for Prevention of AllergyOsborn & Sinn, 2003 - The Cochrane Library

  • Inclusion criteria

    • Randomized trials comparing use of hydrolyzed infant formula to human milk or intact cow milk formula

    •  80% follow-up of subjects

    • 18 / 72 studies were eligible for inclusion

  • Main results

    • Prolonged feeding of hydrolyzed formula (PHF and EHF combined) significantly reduced:

      • Allergy, eczema, cow’s milk allergy incidence in infancy

      • Asthma, food allergy prevalence in childhood

    • No significant difference between PHF and EHF


Slide45 l.jpg
Meta-Analysis: Formulas containingHydrolysed Protein for Prevention of AllergyOsborn & Sinn, 2003 - The Cochrane Library

Reviewer’s conclusions:

  • “When babies are not exclusively breastfed, using hydrolyzed infant formulas instead of ordinary cow’s and soy milk formulas can reduce allergies in babies and children.”

  • “There is insufficient evidence to determine whether feeding with an extensively hydrolyzed formula has any advantage over a partially hydrolyzed formula [for primary allergy prevention].”


Conclusions l.jpg
CONCLUSIONS

  • The prevalence of allergy is on the rise

  • Atopic dermatitis is a common manifestation of allergy in children

  • Allergic disorders have significant impact on the patient and the family

  • There is no good means of predicting those who will develop allergy

  • Traditional preventive strategies are not practical for the general population


Conclusions47 l.jpg
CONCLUSIONS

  • Acceptable cost effective strategies are needed for primary allergy prevention in the general population

  • Breastfeeding should be promoted as the primary means of allergy prevention

  • Current evidence supports the use of extensively hydrolyzed casein and partially hydrolyzed whey formula to reduce the incidence of allergic disease




Family history as allergy predictor l.jpg
Family History as Allergy Predictor

  • Specificity of 86-91%

    • Proportion of true negatives that are correctly identified (will not falsely predict a child at risk most of the time)

  • Sensitivity of 17-22%

    • Proportion of true positives that are correctly identified (will not correctly predict a child at risk most of the time)

Bergmann et al., 1997 Clinical and Experimental allergy 27: 752-60


Prevalence of allergic manifestations by age l.jpg
Prevalence of Allergic Manifestations by Age

Respiratory

GI

Skin

Adapted from Saarinen, 1995; Lancet. 346: 1065-69


Slide52 l.jpg

Population based prevalence of atopic disease in German infantsduring their first 2 years of life according to the history of atopic disease (life-time prevalence) in their parents

Prevalence of Parental Atopic History: 64%31% 5%

Prevalence of Atopic Disease in German Infants (total 17.6%): 9.6% 6.4% 1.6%

Bergman, et al. Clinical and Experimental Allergy 1998; 28:905-907


Odds ratio allergic manifestations extensively hydrolyzed casein vs intact cow milk l.jpg
Odds Ratio — Allergic Manifestations infantsExtensively Hydrolyzed Casein vs. Intact Cow Milk

Von Berg 2003

Zeiger 1995

Oldaeus 1997

Mallet 1992

* Published, peer-reviewed, prospective trials with data collection at timepoints ≤12 months. OR and CI shown in yellow are published values; OR in white and CI in dashed lines are calculated values.

** 9 months: Oldaeus 1997; 12 months: Von Berg 2003, Zeiger 1995, Mallet 1992


Odds ratio atopic dermatitis extensively hydrolyzed casein vs intact cow milk l.jpg
Odds Ratio — Atopic Dermatitis infantsExtensively Hydrolyzed Casein vs. Intact Cow Milk

Von Berg 2003

Zeiger 1995

Oldaeus 1997

Mallet 1992

Chandra 1989 ‡

Osborn meta-analysis 2003

* Published, peer-reviewed, prospective trials with data collection at timepoints ≤12 months. OR and CI shown in black are published values; OR in white and CI in dashed lines are calculated values.

** 9 months: Oldaeus 1997; 12 months: Von Berg 2003, Zeiger 1995, Mallet 1992

‡ Included in Osborn 2003


Odds ratio allergic manifestations partially hydrolyzed whey vs intact cow milk l.jpg
Odds Ratio — Allergic Manifestations infantsPartially Hydrolyzed Whey vs. Intact Cow Milk

Von Berg 2003

Exl 2000

Chandra 1997 ‡

Marini 1996

Vandenplas 1995 ‡

De Seta 1994 ‡

Willems 1993 ‡

Vandenplas 1988

Osborn meta-analysis 2003

* Graph depicts only published, peer-reviewed, prospective trials with data collection at timepoints ≤12 months. OR and CI shown in yellow are published values; OR in white and CI in dashed lines are calculated values.

** 4 months: Vandenplas 1988; 6 months: Exl 2000, De Seta 1994; 12 months: Von Berg 2003, Chandra 1997, Marini 1996, Vandenplas 1995, Willems 1993

‡ Included in Osborn 2003


Odds ratio atopic dermatitis partially hydrolyzed whey vs intact cow milk l.jpg
Odds Ratio — Atopic Dermatitis infantsPartially Hydrolyzed Whey vs. Intact Cow Milk

Von Berg 2003

Chan 2002

Exl 2000

Chandra 1997 ‡

Marini 1996

Vandenplas 1995

De Seta 1994 ‡

Tsai 1991‡

Vandenplas 1988

Osborn meta-analysis 2003

* Graph depicts only published, peer-reviewed, prospective trials with data collection at timepoints ≤12 months. OR and CI shown in yellow are published values; OR in white and CI in dashed lines are calculated values.

** 4 months: Vandenplas 1988; 6 months: Exl 2000, De Seta 1994; 12 months: Von Berg 2003, Chandra 1997, Marini 1996, Vandenplas 1995, Willems 1993

‡ Included in Osborn 2003


Immunologic sensitization l.jpg
Immunologic Sensitization infants

Immunologic sensitization

Re-exposure to sensitizing protein

Manifestations of allergy

Signs and symptoms in target organs

Skin, GI, Lungs


ad